Phase 3 trials showed Vanrafia slowed the decline in kidney function for adults with the progressive autoimmune kidney ...

Most of us think drinking water is simple. You’re either thirsty, so you grab a glass, or you’re not, so you skip it. But our ...

Many people assume that if a supplement is labelled “natural,” it must be safe. But that belief can be misleading. Several ...

Kidneys work quietly in the background, filtering waste, balancing fluids, and maintaining chemical stability without demanding attention. But this is until som ...

Originally developed as a more-potent follow-up to Roche's long-established CD20-directed antibody Rituxan (rituximab) for ...

While proven to help, primary care clinicians have been slow to use the drugs once considered only for patients with diabetes ...

Kidney aging rarely draws attention until something goes wrong. Over time, these organs quietly lose strength, filter less efficiently, and struggle to keep the body balanced.

If Gazyva gains approval in membranous nephropathy, it would have four approved indications under its belt as the drug’s ...

A healthcare professional highlights that when a patient suffers from anaemia, the haemoglobin levels can drop below normal, ...

A total of 340 biopsy-confirmed IgAN patients were randomised to daily oral Vanrafia or a placebo for approximately 132 weeks.

It’s déjà vu all over again. Just as the kidney disease space becomes increasingly competitive, Novartis has found itself intending to turn a statistical miss into a regulatory win. | It’s déjà vu all ...

In an interview, Jackson Peter Kim, MD, clinical assistant professor in the Division of Nephrology at Stanford Health Care, ...